Pilot Study of Pazopanib With Low Fat Meal (PALM) in Advanced Renal Cell Carcinoma
Active, no longer recruiting
Phase of Trial: Phase 0
Latest Information Update: 10 Feb 2018
At a glance
- Drugs Pazopanib (Primary)
- Indications Renal cell carcinoma
- Focus Adverse reactions; Therapeutic Use
- 10 Feb 2018 Results assessing toxicity/safety, bioavailability and anti-tumor efficacy presented at the 2018 Genitourinary Cancers Symposium
- 16 Oct 2017 Status changed from recruiting to active, no longer recruiting.
- 27 Sep 2016 Status changed from not yet recruiting to recruiting.